Fund the elimination of parasitic disease

Unlimit Health works with ministries of health to deliver large-scale, evidence-based programmes that prevent and treat parasitic disease in some of the world’s most affected communities. Our approach is grounded in data and aligned with WHO elimination targets and the UN Sustainable Development Goals.

Kouadio Attuoman a nurse at the CSU in Okrouyo of Côte d'Ivoire.

Funders and partners

Proven, cost-effective delivery

A grant to Unlimit Health translates directly into measurable health impact, strengthening local capacity while accelerating progress towards disease elimination. Our programmes are rigorously monitored, independently evaluated and highly cost-effective, giving funders confidence that their investment will deliver meaningful, lasting change.

A transparent funding partnership

In addition to comprehensive and timely reporting, we offer structured engagement with our leadership and technical teams. Funders may meet with our CEO, Dr Wendy Harrison, alongside programme specialists, to review progress, discuss implementation challenges and explore strategic alignment.

We uphold robust governance, financial management and safeguarding standards, with full policies available here.
Our programme outcomes and global results are documented in detail on our impact page.

For further information or to discuss a potential grant, please contact Lizzy Epsley, Trusts and Foundations Fundraiser, at l.epsley@unlimithealth.org.

Tubs of praziquantel and albendazole, medicines used to treat people affected by parasitic worm infections laid out on a table at a mass drug distribution.

Grants in action

The Life You Can Save: Emergency support in Niger

When USAID funding was withdrawn in early 2025, Niger’s national schistosomiasis treatment campaign was at immediate risk, threatening years of progress.

With £135,200 in funding from The Life You Can Save, Unlimit Health provided rapid financial and technical support to the Ministry of Health, enabling treatment to proceed and reach 1,212,147 school-aged children. The grant protected national gains and ensured continuity of care while longer-term financing solutions are developed.